OFEV® (nintedanib) time to face IPF head on Patients affected by ILD Document ID: PC-ZA-102209 30/06/2023 Author: Boehringer Ingelheim Risk of progression RELATED CONTENT PC-ZA-102209 Production date: July 2023
